Programmable Cell Therapy

Scroll

BioCellTherapy CloudComputing ComputationalBiology GenomeEngineering MachineLearning SoftwareEngineering SyntheticImmunology

ArsenalBio was founded to discover, develop and commercialize curative immune cell therapies

Board of Directors

Brook Byers
Kleiner Perkins
Ken Drazan MD
ArsenalBio
Alexander Marson MD PhD
UCSF
Sean Parker
PICI
Beth Seidenberg MD
Westlake Village BioPartners

Leadership Team

Ken Drazan MD
CEO, President, Director
Jane Grogan PhD
Chief Scientific Officer
Michael Kalos PhD
EVP and Head of R&D
Tarjei Mikkelsen PhD
Chief Technology Officer

Science Founders

Brad Bernstein MD PhD
W. Nicholas Haining BM BCh
Alexander Marson MD PhD
Theo Roth PhD
Kole T. Roybal PhD
E. John Wherry PhD

Scientific Advisors

Howard Y. Chang PhD
Jennifer Doudna PhD
Zemin Zhang PhD
Elaine Fuchs PhD
Ananda Goldrath PhD
Cameron Turtle MBBS PhD

Investors

News

Oct 17, 2019 / ArsenalBio Launches With $85 Million Series A Financing to Advance New Paradigm to Discover and Develop Immune Cell Therapies

Team

Our mission is to create life-saving medicines for patients in need. We’re always looking for talented people who share our vision.

Join our team